Literature DB >> 9013459

HIV infection and the kidney.

V D'Agati1, G B Appel.   

Abstract

HIV-infected patients may present with a variety of patterns of renal involvement. Acute renal failure is common and most often a result of sepsis, hypotension, and nephrotoxic agents. It is potentially avoidable, and support through the period of renal failure may lead to resolution of the renal dysfunction. HIV-associated nephropathy is a unique pattern of sclerosing glomerulopathy that ranges in prevalence from 1 to 10% of the HIV-infected population in different geographic locales. This complication of HIV infection will likely present a growing challenge to the medical community as HIV infection continues to spread worldwide. Deciphering the pathogenetic mechanisms of this most rapidly progressive form of focal segmental sclerosis is not only clinically relevant, but will hopefully provide valuable insights into the mediation of the more common idiopathic form of the disease. The potential for improved renal survival of patients with HIV-associated nephropathy has become more realistic with the development and use of antiretroviral agents, as well as studies on the role of immunosuppression and ACE inhibition in this population. An awareness of other glomerular lesion and tubulointerstitial lesions has broadened our understanding of populations with renal disease who have been infected by HIV. Moreover, as prolonged survival of HIV-infected individuals is being achieved with modern antiviral therapy, the percentage of patients surviving with nephropathy will likely grow in coming years. Awareness of the growth of this population and those requiring short- and long-term hemodialysis and peritoneal dialysis will allow appropriate planning for ESRD in the HIV-infected population.

Entities:  

Mesh:

Year:  1997        PMID: 9013459     DOI: 10.1681/ASN.V81138

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  45 in total

1.  Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.

Authors:  Warren A Andiman; Miriam C Chernoff; Charles Mitchell; Murli Purswani; James Oleske; Paige L Williams; Hans Spiegel; Phil Gona; George R Seage
Journal:  Pediatr Infect Dis J       Date:  2009-07       Impact factor: 2.129

Review 2.  Targeting STAT3 signaling in kidney disease.

Authors:  Jesse Pace; Praharshasai Paladugu; Bhaskar Das; John C He; Sandeep K Mallipattu
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

3.  Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Charles R Swanepoel; Mohamed G Atta; Vivette D D'Agati; Michelle M Estrella; Agnes B Fogo; Saraladevi Naicker; Frank A Post; Nicola Wearne; Cheryl A Winkler; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Christina M Wyatt
Journal:  Kidney Int       Date:  2018-02-03       Impact factor: 10.612

Review 4.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  HIV and kidney disease in sub-Saharan Africa.

Authors:  June Fabian; Saraladevi Naicker
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

6.  Reduction of Stat3 activity attenuates HIV-induced kidney injury.

Authors:  Xiaobei Feng; Ting-Chi Lu; Peter Y Chuang; Wei Fang; Krishna Ratnam; Huabao Xiong; Xinshou Ouyang; Yuhong Shen; David E Levy; Deborah Hyink; Mary Klotman; Vivette D'Agati; Ravi Iyengar; Paul E Klotman; John C He
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

7.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.

Authors:  Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Patrick D Walker
Journal:  J Am Soc Nephrol       Date:  2013-03-21       Impact factor: 10.121

Review 8.  Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy.

Authors:  Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2009-03-14       Impact factor: 3.714

Review 9.  [Virus associated glomerulonephritis].

Authors:  H L Tillmann; A Schwarz
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

10.  Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS.

Authors:  D I Williams; D J Williams; I G Williams; R J Unwin; M H Griffiths; R F Miller
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.